← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sangamo Biosciences, Inc.
Richmond, CA
$927,384
Total funding
6
Grants
Funding mix
By agency
NIH$927,384 · 6
By mechanism
R44$475,604 · 1
R43$403,745 · 4
F32$48,035 · 1
Investigators at Sangamo Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Targeted VEGF Methylation: Novel Cancer Therapy$311,997
R44 · FY2002 · CA
Targeted VEGF Methylation: Novel Cancer Therapy$163,607
R44 · FY2003 · CA
Using Enhanced Gene Targeting to Repair the Sickle Cell$104,000
R43 · FY2004 · HL
ZFN-driven Gene Disruption of CCR5 as a Potential Treatment of AIDS$100,000
R43 · FY2006 · AI
BLOCKING HEPARANASE TRANSCRIPTION TO CONTROL METASTASIS$99,970
R43 · FY2000 · CA
TRANSCRIPTION REPRESSORS TO ANALYZE CANCER GENES$99,775
R43 · FY2000 · CA
CHARACTERIZATION OF SEMAPHORIN IV IN TUMORIGENESIS$33,330
F32 · FY2001 · CA
CHARACTERIZATION OF SEMAPHORIN IV IN TUMORIGENESIS$14,705
F32 · FY2000 · CA